NCT04379310View on ClinicalTrials.gov

Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

May 5, 2020

Study Completion Date

May 8, 2020

Conditions
Covid-19
Interventions
DRUG

ACE Inhibitors and Calcium Channel Blockers

effect of drugs on patients with covid-19 pneumonia

Trial Locations (1)

34230

Vital Hospital, Bahçelievler

All Listed Sponsors
lead

Istanbul Nisantasi University

OTHER

NCT04379310 - Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019) | Biotech Hunter | Biotech Hunter